• Menu
  • About Melanoma
    • Melanoma 101
    • Melanoma & Skin of Color
    • Types of Melanoma
      • Cutaneous Melanoma
      • Acral Melanoma
      • Uveal Melanoma
      • Mucosal Melanoma
      • Other Types of Skin Cancer
    • Melanoma Staging
      • Stage 0
      • Stage 1
      • Stage 2
      • Stage 3
      • Stage 4
      • Breslow Depth and Clark Level
      • Understanding Melanoma Staging
      • Melanoma Survival Rates
    • Statistics
    • Prevention
      • Sunscreen
      • Protective Clothing
      • UV Index
      • Infographics
    • Early Detection
      • What to Look For
      • Monthly Self Exam
      • Full-Body Skin Exam
      • Skin Check Pledge
    • Stories
      • Facing Melanoma Together
      • Patient & Survivor Stories
      • Family & Caregiver Stories
  • For Patients
    • Just Diagnosed
      • Getting Educated About Melanoma
      • Choosing Your Doctor
      • Assembling Your Family & Friends
      • Understanding Your Health Insurance
      • Keeping Your Medical Records Organized
      • Getting a Second Opinion
      • Considering Clinical Trials
      • Connecting with the Melanoma Community
      • Communicating with your Doctor
      • Practicing Self Care
    • Melanoma Treatment
      • Immunotherapy
      • Targeted Therapy
      • Combination Therapy
      • Adjuvant Therapy
      • Therapies in Development
    • Clinical Trials
      • About Clinical Trials
      • Participation and Expectations
      • Benefits and Risks
      • Patient Success Stories
      • Find a Clinical Trial
      • FAQ
      • Questions to Ask
      • Myths Debunked
      • Fight Back Give Back
    • Patient Resources
      • Melanoma > Exchange
      • Glossary of Melanoma Terms
  • Research
    • Research Overview
    • MRA Grant Awards
    • Request for Proposals
      • MRA General RFP
      • MRA/ACS Special Opportunity
      • Dermatology Fellows Award
    • Scientific Retreat
      • 2021 Retreat
      • Future MRA Retreats
      • Previous MRA Retreats
    • Antidote Bridge
    • MRA Grant Mechanisms
  • Get Involved
    • Donate
    • Blog
    • Sign Up for Emails
    • Events
      • Leveraged Finance Fights Melanoma
      • Melanoma Exchange Patient Forum
    • Fundraise for MRA
      • Online Fundraising Opportunities
      • Host an Event
    • Honor a Loved One
      • Memorial Tribute Information
    • Sponsor a Named Award
    • Corporate Partnerships
    • Workplace Giving
  • About MRA
    • MRA Overview
    • Board of Directors
      • Debra Black
      • Leon Black
      • Ben Black
      • Margaret Anderson
      • Maria Bell
      • Ellen Davis
      • Amanda Eilian
      • Jason Daniel Federici
      • Jami Gertz
      • Daisy Helman
      • Susan Hess
      • Denise Kellen
      • Michael Klowden
      • Nancy Marks
      • Michael Milken
      • Richard Ressler
      • Mary Jo Rogers
      • Jeffrey Rowbottom
      • Elliott Sigal, M.D., Ph.D.
      • Jonathan W. Simons, M.D.
      • Jonathan Sokoloff
      • Elizabeth Stanton
      • Suzanne L. Topalian, M.D.
    • Staff
      • Michael Kaplan
      • Marc Hurlbert
      • Kristen Mueller
      • Joan Levy
      • Cody Barnett
      • Carolyn Ricci
      • Janine Rauscher
      • Tyler Brown
      • Rachel Fischer
      • Renee Orcione
    • Scientific Advisory Panel
    • Grant Review Committee
    • Medical Advisory Panel
    • Dermatology Council
    • MRA Press Releases
    • Financials
    • Careers
    • Corporate Allies
    • Annual Reports

       
DONATE
  • Five Melanoma Research Highlights for 2021

    Without doubt, much will be written about 2020 in the years to come - from the news headlines of COVID-19 and the US elections, to melanoma specific achievements such as exciting clinical trials results and our own efforts to fuel a revolution in research. Today, however, we choose to look forward to the near horizon and to share the top five items that has our team excited for the coming year in the fight against melanoma.

    Read More
  • Creating Art to Create Change: The Power to Heal & Mobilize Community

    Following the initial shock of her melanoma diagnosis and the strain of facing treatments on her own because of COVID-19, Barbara was faced with yet another hurdle. Her arm surgery had left it nearly immobile. Not only was this a problem for her daily functioning, it made it extremely difficult for Barbara to pursue her lifelong passion of art.

    Read More
  • From Stage 4 to NED (No Evidence of Disease) Through a Clinical Trial

    Today, Gail has been โ€˜offโ€™ treatment for over a year. Her scans โ€“ first every three months, now relaxed to four, and soon to six months โ€“ continue to show no evidence of disease. She is now a staunch proponent of clinical trials, getting a second opinion, and for sticking up for yourself throughout the process. This is Gail's story.

    Read More
  • Fueling a Revolution

    MRA is powering a revolution in melanoma research. A revolution that is not only benefiting patients with melanoma but also impacting the field of oncology at large.

    Despite immense progress, there are still too many patients who are not yet benefiting from even the latest advancements. To address this, MRA is investing in research to identify predictive biomarkers, innovative telemedicine models of care, and big data and artificial intelligence to help move the field ahead.

    Read the Report
  • Exciting Melanoma Clinical Trial Results

    The annual Society for the Immunotherapy for Cancer (SITC) meeting did not disappoint, despite its virtual format, when it came to new clinical advances for melanoma. Researchers presented data from several important clinical trials and highlighted several novel agents that may boost responses to checkpoint immunotherapy.

    Read More
  • Find a Clinical Trial

    Melanoma Clinical Trial Finder
  • Get Connected

    Find Support for melanoma
  • Scientific Report

    Retreat Report Box 2020
  • Get Involved

    Get Involved with Melanoma Outreach
  • About MRA

    Melanoma video

What's New

01/11/2021 – Creating Art to Create Change: The Power to Heal & Mobilize Community

01/01/2021 – Reimagining Melanoma Research During and After the Pandemic

12/28/2020 – Leading Organizations Applaud Congress on $30 Million Dedicated to Melanoma Research within the Department of Defense FY21 Appropriations

12/11/2020 – Exciting End of Year Melanoma Clinical Trial Results

12/08/2020 – Mary Jo Rogers: Research Will Get Us There

Login

I've lost my password

×

MRA would like to thank our 2020 Scientific Retreat Sponsors

  • Presenting Sponsor

    Bristol-Myers Squibb
    • Platinum Sponsors

    • Amgen Oncology
    • Merck
    • Novartis
  • Gold Sponsors

    • Array Biopharma
    • Johnson & Johnson
    • NEKTAR
    • Radimmune

Melanoma Research Alliance

730 15th Street, NW
Washington, DC 20005
(202) 336-8935

info@curemelanoma.org
#14131

About MRA

As the largest non-profit funder of melanoma research, MRA has dedicated $123 million to date in support of the fight against melanoma.

Privacy Statement